Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC).

education & training (see medical education & training) epidemiology statistics & research methods

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 12 2020
Historique:
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 26 2 2021
Statut: epublish

Résumé

Methodological studies (ie, studies that evaluate the design, conduct, analysis or reporting of other studies in health research) address various facets of health research including, for instance, data collection techniques, differences in approaches to analyses, reporting quality, adherence to guidelines or publication bias. As a result, methodological studies can help to identify knowledge gaps in the methodology of health research and strategies for improvement in research practices. Differences in methodological study names and a lack of reporting guidance contribute to lack of comparability across studies and difficulties in identifying relevant previous methodological studies. This paper outlines the methods we will use to develop an evidence-based tool-the MethodologIcal STudy reportIng Checklist-to harmonise naming conventions and improve the reporting of methodological studies. We will search for methodological studies in the Cumulative Index to Nursing and Allied Health Literature, Cochrane Library, Embase, MEDLINE, Web of Science, check reference lists and contact experts in the field. We will extract and summarise data on the study names, design and reporting features of the included methodological studies. Consensus on study terms and recommended reporting items will be achieved via video conference meetings with a panel of experts including researchers who have published methodological studies. The consensus study has been exempt from ethics review by the Hamilton Integrated Research Ethics Board. The results of the review and the reporting guideline will be disseminated in stakeholder meetings, conferences, peer-reviewed publications, in requests to journal editors (to endorse or make the guideline a requirement for authors), and on the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) Network and reporting guideline websites. We have registered the development of the reporting guideline with the EQUATOR Network and publicly posted this project on the Open Science Framework (www.osf.io/9hgbq).

Identifiants

pubmed: 33334836
pii: bmjopen-2020-040478
doi: 10.1136/bmjopen-2020-040478
pmc: PMC7747548
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e040478

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: ‘Yes, there are competing interests for one or more authors and I have provided a Competing Interests statement in my manuscript and in the box below’.

Références

J Clin Epidemiol. 2020 May;121:55-61
pubmed: 31982541
J Clin Epidemiol. 2006 Jul;59(7):697-703
pubmed: 16765272
Ann Intern Med. 2019 Jan 1;170(1):51-58
pubmed: 30596875
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Pilot Feasibility Stud. 2020 Jan 30;6:13
pubmed: 32699641
J Clin Epidemiol. 2016 Jul;75:40-6
pubmed: 27005575
J Clin Epidemiol. 2017 Aug;88:57-66
pubmed: 28583378
Circ Cardiovasc Qual Outcomes. 2019 May;12(5):e005260
pubmed: 31030545
BMJ. 1995 Aug 5;311(7001):376-80
pubmed: 7640549
PLoS Med. 2010 Feb 16;7(2):e1000217
pubmed: 20169112
Am J Phys Med Rehabil. 2017 Jan;96(1):34-44
pubmed: 27149591
J Clin Epidemiol. 2020 Mar;119:57-64
pubmed: 31734347
Pilot Feasibility Stud. 2016 May 20;2:25
pubmed: 27965844
BMC Med Res Methodol. 2016 Feb 18;16:20
pubmed: 26891992
PLoS Med. 2012;9(10):e1001333
pubmed: 23222917
Contemp Clin Trials. 2014 Jul;38(2):245-50
pubmed: 24861557
J Multidiscip Healthc. 2018 Sep 27;11:495-510
pubmed: 30310289
J Multidiscip Healthc. 2013 May 06;6:169-88
pubmed: 23671390
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
J Clin Epidemiol. 2017 Apr;84:61-69
pubmed: 28063913
Contemp Clin Trials. 2018 Feb;65:144-150
pubmed: 29287666
BMC Med Res Methodol. 2007 Nov 29;7:52
pubmed: 18045508
Epidemiol Health. 2014 Sep 25;36:e2014019
pubmed: 25266419
J Clin Epidemiol. 2019 Aug;112:93
pubmed: 31048023
Syst Rev. 2017 Dec 19;6(1):263
pubmed: 29258593
Trials. 2017 Jan 21;18(1):32
pubmed: 28109324
Lancet. 2014 Jan 18;383(9913):257-66
pubmed: 24411650
BMJ. 2012 Mar 15;344:e1553
pubmed: 22422832
BMC Med Res Methodol. 2017 Dec 29;17(1):181
pubmed: 29287585
J Clin Epidemiol. 2019 Aug;112:93-95
pubmed: 31048022
Lancet. 2014 Jan 11;383(9912):166-75
pubmed: 24411645
Contemp Clin Trials. 2005 Aug;26(4):480-7
pubmed: 16054580
FASEB J. 2005 May;19(7):673-80
pubmed: 15857882
Evid Based Med. 2017 Aug;22(4):139-142
pubmed: 28701372
Lancet. 2009 Jul 4;374(9683):86-9
pubmed: 19525005
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
BMC Med Res Methodol. 2018 May 21;18(1):44
pubmed: 29783954
JAMA. 2001 Apr 18;285(15):1992-5
pubmed: 11308436
J Clin Epidemiol. 2019 Jun;110:98-99
pubmed: 30742887
J Clin Epidemiol. 2020 May;121:110-112
pubmed: 32004672
Fam Med. 2005 May;37(5):360-3
pubmed: 15883903
BMJ. 2014 Jun 25;348:g3804
pubmed: 24965222
Br J Dermatol. 2020 Jun;182(6):1469-1476
pubmed: 31529461
Pilot Feasibility Stud. 2016 Oct 21;2:64
pubmed: 27965879
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
BMJ Open. 2018 Oct 24;8(10):e025054
pubmed: 30361409
PLoS One. 2013 Aug 26;8(8):e64733
pubmed: 23990867
PLoS Biol. 2018 Mar 13;16(3):e2005468
pubmed: 29534060
J Clin Epidemiol. 2019 Sep;113:159-167
pubmed: 31132471
J Clin Epidemiol. 2017 Aug;88:47-56
pubmed: 28603010
Perspect Psychol Sci. 2019 Nov;14(6):1105-1108
pubmed: 31449761
J Clin Epidemiol. 2009 Oct;62(10):1006-12
pubmed: 19631508
Int J Pharm Pract. 2020 Jun;28(3):220-232
pubmed: 31573121
Can J Surg. 2007 Aug;50(4):266-77
pubmed: 17897515

Auteurs

Daeria O Lawson (DO)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada lawsod3@mcmaster.ca.

Livia Puljak (L)

Center for Evidence-Based Medicine and Health Care, Catholic University of Croatia, Zagreb, Croatia.

Dawid Pieper (D)

Institute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.

Stefan Schandelmaier (S)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University and University Hospital of Basel, Basel, Switzerland.

Gary S Collins (GS)

Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

Romina Brignardello-Petersen (R)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

David Moher (D)

Centre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Peter Tugwell (P)

School of Epidemiology and Public Health, Faculty of Medicine and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Bruyère Research Institute, Ottawa, Ontario, Canada.

Vivian A Welch (VA)

School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Bruyère Research Institute, Ottawa, Ontario, Canada.

Zainab Samaan (Z)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Brett D Thombs (BD)

Faculty of Medicine, McGill University, Montreal, Quebec, Canada.
Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.

Anders K Nørskov (AK)

Copenhagen Trial Unit, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Janus C Jakobsen (JC)

Copenhagen Trial Unit, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Department of Regional Health Research, The Faculty of Heath Sciences, University of Southern Denmark, Odense, Denmark.

David B Allison (DB)

Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, USA.

Evan Mayo-Wilson (E)

Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, USA.

Taryn Young (T)

Centre for Evidence-based Health Care, Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

An-Wen Chan (AW)

Department of Medicine, Women's College Research Institute, University of Toronto, Toronto, Ontario, Canada.

Matthias Briel (M)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Institute for Clinical Epidemiology and Biostatistics, Department of Clinical Research, University and University Hospital of Basel, Basel, Switzerland.

Gordon H Guyatt (GH)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.

Lehana Thabane (L)

Department of Health Research Methods, Evidence, and Impact, and Departments of Paediatrics and Anaesthesia, McMaster University, Hamilton, Ontario, Canada.
Biostatistics Unit, Father Sean O'Sullivan Research Centre and Centre for Evaluation of Medicine, Saint Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.
Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada.

Lawrence Mbuagbaw (L)

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
Biostatistics Unit, Father Sean O'Sullivan Research Centre, Saint Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH